Clinical Trials
3 trialsNCT01304797 2017-01-06
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Merrimack Pharmaceuticals
Phase 1 Unknown
NCT01880385 2013-06-19
Beva
Association Tunisienne de lutte Contre le Cancer
Phase 1 Unknown
NCT00367250 2010-09-28
Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
Medical University of Vienna
Phase 1 Unknown